logo
  • SELECT LICENSE :

  • US $4,299.00
  • US $8,599.00

Immunodiagnostics Market, by product (Immunodiagnostic Systems and Reagents & Consumables), application (Hepatitis and Retrovirus, GI Stool, Oncology and Endocrinology Infectious Disease, and Other Applications), end-user (Hospitals & Diagnostic Laboratories and PPLs), and opportunities and forecast 2020-2027

  • DLR2285
  • 09 February, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global
Immunodiagnostics Market Overview

The growing adoption of the point-of-care testing (POCT) will drive growth prospects for global immunodiagnostics market until end of 2027. Few of life-threatening conditions which need thoughtful attention include acute cardiac infarction and sepsis. Such serious situations with high death rate drive necessity for the POCT, which, in turn, increases the demand for the immunodiagnostics testing. One of areas of focus for the non-traditional and traditional healthcare companies are the POCT for cardiovascular biomarkers. Moreover, POCT is accurate, fast, portable, and very simple to interpret, that helps healthcare providers in alternate healthcare settings. Furthermore, the cost of the POCT is very low because of the small capillary tubes which need fewer reagents.

Significant progression in immunodiagnostics have enhanced diagnosis of the complex interactive network. Increase in prevalence and incidences of infectious diseases (such as HIV, hepatitis, STDs, and others), cardiovascular diseases (CVDs), cancers, and various other chronic diseases have advanced immunodiagnostics market. Additionally, rising geriatric population and altering lifestyle and demographics supplementary propel market. Growing awareness and technological advancements about immunodiagnostics drive global market. Though stringent regulatory scenarios confine global immunodiagnostics market.

Immunodiagnostics Market Segment Overview

Rise in incidences of various infectious diseases (including HIV, hepatitis B, STI, and others), CVDs, cancer, gastrointestinal, and various other chronic diseases around world owing to growth in elderly population and changes in the demographics and lifestyle are major factors to drive growth of immunodiagnostics market. In addition, technical advancement in assays, diagnosis kits, and analysers and surge in awareness of preventive health measures among medical professionals and patient further stimulate demand for various immunodiagnostics products hence boosting growth. Though, numerous factors are anticipated to restrain market development. Impact of drivers is projected to be higher than restraints. Moreover, increase in effect of drivers and restraints is expected to reveal various new market opportunities for the key players manufacturing the immunodiagnostics products especially assays and kits.

Immunodiagnostics Regional Overview

North America was largest immunodiagnostics market in 2020, and region will offer numerous growth opportunities to the market vendors over the forecast period. Aspects such as fast-growing elderly population and high prevalence of various chronic and infectious diseases will meaningfully drive the immunodiagnostics market growth in the region throughout forecast period.

Asia-Pacific region is predictable to grow with highest CAGR during forecast period owed to improvement in favorable regulatory reforms, public and private healthcare facility, presence of large population pool, and growing chronic diseases.

Immunodiagnostics Market Competitor overview

The market for immunodiagnostics is concentrated. The major players are concentrating on developing advanced technologies to improve performance parameters of the immunodiagnostics. Since global immunodiagnostics market is in growth phase, major vendors are challenging each other to consolidate the position in market and to attract new customers.

Immunodiagnostics Market, Key Players

•      Abbott Laboratories
•      bioMérieux SA
•      Danaher Corp.
•      F. Hoffmann-La Roche Ltd.
•      OraSure Technologies Inc.
•      Quest Diagnostics Inc.
•      Siemens AG
•      Sysmex Corp.
•      Tecan Group Ltd.
•      Thermo Fisher Scientific Inc.

Immunodiagnostics Market Segmentation

Immunodiagnostics Market, By Products

•      Reagents and consumables
•      Immunodiagnostic systems

Immunodiagnostics Market, By Application

•      Oncology and endocrinology
•      Hepatitis and retrovirus
•      Infectious disease
•      GI stool
•      Other applications

Immunodiagnostics Market, By End Use

•      Hospitals
•      Diagnostic laboratories
•      PPLs

Immunodiagnostics market, By Region:
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa


Immunodiagnostics MARKET STUDY GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Immunodiagnostics Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Segment 1
        • 5.2.1. Sub-Segment 1
        • 5.2.2. Sub-Segment 2
      • 5.3. Market Analysis, Insights and Forecast – By Segment 2
        • 5.3.1. Sub-Segment 1
        • 5.3.2. Sub-Segment 2
        • 5.3.3. Sub-Segment 3
        • 5.3.4. Others
      • 5.4. Market Analysis, Insights and Forecast – By Segment 3
        • 5.4.1. Sub-Segment 1
        • 5.4.2. Sub-Segment 2
        • 5.4.3. Sub-Segment 3
        • 5.4.4. Others
      • 5.5. Market Analysis, Insights and Forecast – By Region
        • 5.5.1. North America
        • 5.5.2. Latin America
        • 5.5.3. Europe
        • 5.5.4. Asia Pacific
        • 5.5.5. Middle East and Africa

      6. North America Immunodiagnostics Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Segment 1
        • 6.2.1. Sub-Segment 1
        • 6.2.2. Sub-Segment 2
      • 6.3. Market Analysis, Insights and Forecast – By Segment 2
        • 6.3.1. Sub-Segment 1
        • 6.3.2. Sub-Segment 2
        • 6.3.3. Sub-Segment 3
        • 6.3.4. Others
      • 6.4. Market Analysis, Insights and Forecast – By Segment 3
        • 6.4.1. Sub-Segment 1
        • 6.4.2. Sub-Segment 2
        • 6.4.3. Sub-Segment 3
        • 6.4.4. Others
      • 6.5. Market Analysis, Insights and Forecast – By Country
        • 6.5.1. U.S.
        • 6.5.2. Canada

      7. Latin America Immunodiagnostics Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Segment 1
        • 7.2.1. Sub-Segment 1
        • 7.2.2. Sub-Segment 2
      • 7.3. Market Analysis, Insights and Forecast – By Segment 2
        • 7.3.1. Sub-Segment 1
        • 7.3.2. Sub-Segment 2
        • 7.3.3. Sub-Segment 3
        • 7.3.4. Others
      • 7.4. Market Analysis, Insights and Forecast – By Segment 3
        • 7.4.1. Sub-Segment 1
        • 7.4.2. Sub-Segment 2
        • 7.4.3. Sub-Segment 3
        • 7.4.4. Others
      • 7.5. Insights and Forecast – By Country
        • 7.5.1. Brazil
        • 7.5.2. Mexico
        • 7.5.3. Rest of Latin America

      8. Europe Immunodiagnostics Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Segment 1
        • 8.2.1. Sub-Segment 1
        • 8.2.2. Sub-Segment 2
      • 8.3. Market Analysis, Insights and Forecast – By Segment 2
        • 8.3.1. Sub-Segment 1
        • 8.3.2. Sub-Segment 2
        • 8.3.3. Sub-Segment 3
        • 8.3.4. Others
      • 8.4. Market Analysis, Insights and Forecast – By Segment 3
        • 8.4.1. Sub-Segment 1
        • 8.4.2. Sub-Segment 2
        • 8.4.3. Sub-Segment 3
        • 8.4.4. Others
      • 8.5. Market Analysis, Insights and Forecast – By Country
        • 8.5.1. UK
        • 8.5.2. Germany
        • 8.5.3. France
        • 8.5.4. Italy
        • 8.5.5. Spain
        • 8.5.6. Russia
        • 8.5.7. Rest of Europe

      9. Asia Pacific Immunodiagnostics Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Segment 1
        • 9.2.1. Sub-Segment 1
        • 9.2.2. Sub-Segment 2
      • 9.3. Market Analysis, Insights and Forecast – By Segment 2
        • 9.3.1. Sub-Segment 1
        • 9.3.2. Sub-Segment 2
        • 9.3.3. Sub-Segment 3
        • 9.3.4. Others
      • 9.4. Market Analysis, Insights and Forecast – By Segment 3
        • 9.4.1. Sub-Segment 1
        • 9.4.2. Sub-Segment 2
        • 9.4.3. Sub-Segment 3
        • 9.4.4. Others
      • 9.5. Market Analysis, Insights and Forecast – By Country
        • 9.5.1. China
        • 9.5.2. India
        • 9.5.3. Japan
        • 9.5.4. Australia
        • 9.5.5. South East Asia
        • 9.5.6. Rest of Asia Pacific

      10. Middle East & Africa Immunodiagnostics Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 10.1. Key Findings / Summary
      • 10.2. Market Analysis, Insights and Forecast – By Segment 1
        • 10.2.1. Sub-Segment 1
        • 10.2.2. Sub-Segment 2
      • 10.3. Market Analysis, Insights and Forecast – By Segment 2
        • 10.3.1. Sub-Segment 1
        • 10.3.2. Sub-Segment 2
        • 10.3.3. Sub-Segment 3
        • 10.3.4. Others
      • 10.4. Market Analysis, Insights and Forecast – By Segment 3
        • 10.4.1. Sub-Segment 1
        • 10.4.2. Sub-Segment 2
        • 10.4.3. Sub-Segment 3
        • 10.4.4. Others
      • 10.5. Market Analysis, Insights and Forecast – By Country
        • 10.5.1. GCC
        • 10.5.2. South Africa
        • 10.5.3. Rest of Middle East & Africa

      11. Competitive Analysis

      • 11.1. Company Market Share Analysis, 2018
      • 11.2. Key Industry Developments
      • 11.3. Company Profile
        • 11.3.1. Company 1
          • 11.3.1.1. Business Overview
          • 11.3.1.2. Segment 1 & Service Offering
          • 11.3.1.3. Overall Revenue
          • 11.3.1.4. Geographic Presence
          • 11.3.1.5. Recent Development
        *Similar details will be provided for the following companies
        • 11.3.2. Company 2
        • 11.3.3. Company 3
        • 11.3.4. Company 4
        • 11.3.5. Company 5
        • 11.3.6. Company 6
        • 11.3.7. Company 7
        • 11.3.8. Company 8
        • 11.3.9. Company 9
        • 11.3.10. Company 10
        • 11.3.11. Company 11
        • 11.3.12. Company 12
      List of Figures

      Figure 1: Global Immunodiagnostics Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
      Figure 2: Global Immunodiagnostics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 3: Global Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 4: Global Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 5: Global Immunodiagnostics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 6: Global Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 7: Global Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 8: Global Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 9: Global Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 10: Global Immunodiagnostics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 11: Global Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 12: Global Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 13: Global Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 14: Global Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 15: Global Immunodiagnostics Market Value (USD Billion), by Region, 2019 & 2027
      Figure 16: North America Immunodiagnostics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 17: North America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 18: North America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 19: North America Immunodiagnostics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 20: North America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 21: North America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 22: North America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 23: North America Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 24: North America Immunodiagnostics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 25: North America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 26: North America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 27: North America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 28: North America Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 29: North America Immunodiagnostics Market Forecast (USD Billion), by U.S., 2016-2027
      Figure 30: North America Immunodiagnostics Market Forecast (USD Billion), by Canada, 2016-2027
      Figure 31: Latin America Immunodiagnostics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 32: Latin America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 33: Latin America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 34: Latin America Immunodiagnostics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 35: Latin America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 36: Latin America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 37: Latin America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 38: Latin America Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 39: Latin America Immunodiagnostics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 40: Latin America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 41: Latin America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 42: Latin America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 43: Latin America Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 44: Latin America Immunodiagnostics Market Forecast (USD Billion), by Brazil, 2016-2027
      Figure 45: Latin America Immunodiagnostics Market Forecast (USD Billion), by Mexico, 2016-2027
      Figure 46: Latin America Immunodiagnostics Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
      Figure 47: Europe Immunodiagnostics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 48: Europe Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 49: Europe Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 50: Europe Immunodiagnostics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 51: Europe Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 52: Europe Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 53: Europe Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 54: Europe Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 55: Europe Immunodiagnostics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 56: Europe Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 57: Europe Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 58: Europe Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 59: Europe Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 60: Europe Immunodiagnostics Market Forecast (USD Billion), by U.K., 2016-2027
      Figure 61: Europe Immunodiagnostics Market Forecast (USD Billion), by Germany, 2016-2027
      Figure 62: Europe Immunodiagnostics Market Forecast (USD Billion), by France, 2016-2027
      Figure 63: Europe Immunodiagnostics Market Forecast (USD Billion), by Italy, 2016-2027
      Figure 64: Europe Immunodiagnostics Market Forecast (USD Billion), by Spain, 2016-2027
      Figure 65: Europe Immunodiagnostics Market Forecast (USD Billion), by Russia, 2016-2027
      Figure 66: Europe Immunodiagnostics Market Forecast (USD Billion), by Rest of Europe, 2016-2027
      Figure 67: Asia Pacific Immunodiagnostics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 68: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 69: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 70: Asia Pacific Immunodiagnostics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 71: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 72: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 73: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 74: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 75: Asia Pacific Immunodiagnostics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 76: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 77: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 78: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 79: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 80: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by China, 2016-2027
      Figure 81: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by India, 2016-2027
      Figure 82: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Japan, 2016-2027
      Figure 83: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Australia, 2016-2027
      Figure 84: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Southeast Asia, 2016-2027
      Figure 85: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
      Figure 86: Middle East & Africa Immunodiagnostics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 87: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 88: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 89: Middle East & Africa Immunodiagnostics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 90: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 91: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 92: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 93: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 94: Middle East & Africa Immunodiagnostics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 95: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 96: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 97: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 98: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 99: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by GCC, 2016-2027
      Figure 100: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by South Africa, 2016-2027
      Figure 101: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
      List of Tables
      Table 1: Global Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 2: Global Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 3: Global Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 4: Global Immunodiagnostics Market Revenue (USD Billion) Forecast, by Region, 2016-2027
      Table 5: North America Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 6: North America Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 7: North America Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 8: North America Immunodiagnostics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 9: Europe Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 10: Europe Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 11: Europe Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 12: Europe Immunodiagnostics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 13: Latin America Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 14: Latin America Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 15: Latin America Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 16: Latin America Immunodiagnostics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 17: Asia Pacific Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 18: Asia Pacific Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 19: Asia Pacific Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 20: Asia Pacific Immunodiagnostics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 21: Middle East & Africa Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 22: Middle East & Africa Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 23: Middle East & Africa Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 24: Middle East & Africa Immunodiagnostics Market Revenue (USD Billion) Forecast, by Country, 2016-2027

      Report You Might be Interested